UnitedHealth Group Inc. UNH is making artificial intelligence a bigger part of its strategy to strengthen Optum Insight’s growth. The company plans to invest nearly $1.5 billion in AI-related initiatives in 2026, with about one-third earmarked for software products and platforms. The spending is supporting a broader shift toward an AI-first software and services model, giving Optum Insight an opportunity to develop new revenue streams while improving healthcare workflows.
The strategy is moving beyond experimentation into commercial products. Optum Insight is expanding AI capabilities across autonomous coding, digital prior authorization, real-time payer-provider interfaces and clinical quality and safety tools. Digital prior authorization is showing early traction, with AI achieving a 96% first-pass approval rate while retaining human review for cases that are not approved. These solutions could strengthen Optum Insight’s value proposition as payers and providers seek to reduce administrative costs.
Value Connect offers another example of AI translating into measurable customer benefits. The platform, embedded within provider workflows and electronic health records, has helped early customers achieve a 17% reduction in pharmacy costs. Demonstrated savings could support wider adoption as healthcare organizations increasingly seek technology that delivers measurable financial and clinical benefits.
The underlying business is also gaining momentum. Optum Insight generated $5.4 billion in second-quarter 2026 revenues, while operating earnings increased 13.6% year over year and margin improved to 25.3%. As AI products move toward broader commercialization, the strategy could provide another growth lever. Converting early customer results into wider adoption and recurring revenue will be key to strengthening Optum Insight’s growth trajectory.
How Are Competitors Faring?
Some of UNH’s major competitors in the healthcare service provider space are Humana Inc. HUM and Centene Corporation CNC.
Humana is expanding AI across care management, prior authorization and member engagement to improve efficiency and health outcomes. HUM is also using predictive analytics to identify high-risk members earlier, supporting value-based care while helping manage medical costs and streamline healthcare delivery.
Centene is using AI to strengthen payment integrity and manage rising healthcare costs. CNC’s advanced analytics help detect suspicious claims, identify billing anomalies and improve medical cost management, supporting margins while enhancing oversight across its government-sponsored healthcare programs.
UnitedHealth’s Price Performance, Valuation & Estimates
Shares of UNH have gained 41.9% over the past six months compared with the industry’s rise of 41.7%.

Image Source: Zacks Investment Research
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 18.48, above the industry average of 16.02. UNH carries a Value Score of B.

Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UnitedHealth’s 2026 earnings is pegged at $19.82 per share, implying 21.2% growth from the year-ago period.

Image Source: Zacks Investment Research
UNH stock currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
Humana Inc. (HUM): Free Stock Analysis Report
Centene Corporation (CNC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research